Published in Urology on June 01, 1998
Retracted Collecting duct carcinoma of the kidney: a clinicopathological study of five cases. Diagn Pathol (2013) 1.38
Topoisomerase II alpha status in renal medullary carcinoma: immuno-expression and gene copy alterations of a potential target of therapy. J Urol (2009) 0.97
Renal medullary carcinoma: case report of an aggressive malignancy with near-complete response to dose-dense methotrexate, vinblastine, Doxorubicin, and Cisplatin chemotherapy. Case Rep Oncol Med (2014) 0.75
Superficial bladder cancer: progression and recurrence. J Urol (1983) 2.30
Microsurgical denervation of the spermatic cord as primary surgical treatment of chronic orchialgia. J Urol (2001) 1.97
Transurethral microwave thermotherapy for management of benign prostatic hyperplasia: results of the United States Prostatron Cooperative Study. J Urol (1993) 1.46
Association of pheochromocytomas with brown fat tumors. Radiology (1973) 1.40
Laurence-Moon-Biedl syndrome, associated with multiple genitourinary tract anomalies. Am J Dis Child (1969) 1.34
Microsurgical denervation of the spermatic cord: a surgical alternative in the treatment of chronic orchialgia. J Urol (1996) 1.10
Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone. Cancer (1983) 1.04
Changes in radical prostatectomy and radiation therapy rates for African Americans and whites. J Natl Med Assoc (2000) 0.90
Immunobiology of the Dunning R-3327 rat prostate adenocarcinoma sublines: plasma and tumor effusion prostaglandins. Am J Reprod Immunol Microbiol (1985) 0.87
Gross hematuria and abdominal aortic aneurysm. J Urol (1967) 0.82
Heterotopic adrenocortical adenoma producing primary aldosteronism. J Urol (1967) 0.82
Congenital unilateral multicystic disease of the kidney. Arch Surg (1968) 0.81
Combination therapy using polyamine synthesis inhibitor alpha-difluoromethylornithine and adriamycin in treatment of rats carrying the Dunning R3327 MAT-LyLu prostatic adenocarcinoma. Prostate (1987) 0.79
Percutaneous cryoablation of the prostate: preliminary results after 95 procedures. J Urol (1995) 0.79
Application of immunohistologic staining to develop a malignant index to aid in distinguishing benign from malignant prostatic tissue. Prostate (1989) 0.79
Evaluation of bladder washing cytology for bladder cancer surveillance. J Urol (1978) 0.78
Comparison of estramustine phosphate, methotrexate and cis-platinum in patients with advanced, hormone refractory prostate cancer. J Urol (1983) 0.78
Effect of cyclophosphamide on leukocytic subset distributions in rats carrying the Dunning R3327-MAT-LyLu prostatic adenocarcinoma. Prostate (1987) 0.78
Combined suture and methyl 2-cyanoacrylate monomer for reanastomosis of the ureter. Trans Am Assoc Genitourin Surg (1967) 0.78
Severe pancytopenia associated with the use of intravesical thio-TEPA. J Urol (1967) 0.77
The effect of low-dose cyclophosphamide and immunologic exposure upon growth of established Dunning R-3327-G subline rat prostate adenocarcinomas. Prostate (1985) 0.75
Characterization of cellular infiltrates in the rat urinary bladder following BCG and thiotepa intravesical therapy. J Surg Oncol (1991) 0.75
Re: In vitro characterization of Mat LyLu: a Dunning rat prostate adenocarcinoma tumor subline. J Urol (1985) 0.75
The addition of chemotherapy to hormonal therapy for treatment of patients with metastatic carcinoma of the prostate. J Surg Oncol (1983) 0.75
An unusual pitfall in the conservative management of reflux. J Urol (1972) 0.75
GM-CSF restoration of a differentiated (growth factor-regulated) phenotype in an anaplastic tumor. Urol Res (1991) 0.75
Combined suture and methyl 2-cyanocrylate monomer for reanastomosis of the ureter. J Urol (1968) 0.75
Tryptophan urinary bladder absorption and bladder cancer. Invest Urol (1975) 0.75
Renal artery aneurysms: a report of 16 cases. J Urol (1966) 0.75
Effect of BCG upon functional and phenotypic immune markers in rats bearing the Dunning R3327 MAT-LyLu prostatic adenocarcinoma. Immunopharmacol Immunotoxicol (1988) 0.75
Review of acid phosphatase in the diagnosis and prognosis of prostatic cancers. Clin Physiol Biochem (1988) 0.75
Administration of recombinant tumor necrosis factor to rats bearing the Dunning R3327 MAT-LyLu prostatic adenocarcinoma. Clin Physiol Biochem (1987) 0.75
Removal of bladder stones in females. Urology (1978) 0.75
Partial nephrectomy for hypernephroma occurring in a solitary kidney. J Urol (1967) 0.75
Rapid freezing of the prostate: an experimental study. J Urol (1966) 0.75
Tumor infiltrating lymphocytes: the effect of bacillus Calmette Guerin on helper/suppressor-T cell ratios of treated and untreated tumors. J Urol (1991) 0.75
Suprapubic cystostomy: a simplified technique. Urology (1978) 0.75
Endometriosis of the bladder: case report. J Urol (1966) 0.75
Transperineal urethral resection of the prostate. J Urol (1972) 0.75
Acquired immunodeficiency syndrome presenting as testicular lymphoma. J Urol (1992) 0.75
Leukocytic subset distributions of spleen cells obtained from rats bearing variants of the Dunning prostatic adenocarcinoma. J Urol (1986) 0.75
Ureteroureteral anastomosis using methyl-2-cyanoacrylate monomer. J Urol (1966) 0.75
Marshall-Marchetti procedure: modification. J Urol (1966) 0.75
Coordinate loss of growth regulatory factors following castration of rats carrying the Dunning R3327 G prostatic tumor. Clin Physiol Biochem (1992) 0.75
New transurethral system for interstitial radiation of prostate cancer. J Surg Oncol (1988) 0.75
The effect of hormone therapy on peripheral blood leukocytic subset distribution in stage D prostatic cancer patients. Urol Res (1985) 0.75
Saggital sinus repair. Technical note. J Neurosurg (1973) 0.75
Surgery of testicular tumors. Surg Clin North Am (1969) 0.75
Responsiveness of lymphocytes to soluble extracts of prostatic tumors and abrogation by serum-blocking factor(s). Urology (1977) 0.75
Immunoregulatory markers in rats carrying Dunning R3327 H, G, or MAT-LyLu prostatic adenocarcinoma variants. Cancer Res (1987) 0.75